Laurel Elizabeth Busch, OTR/L | |
10685 101st Ave Nw, Columbus, ND 58727-9420 | |
(701) 339-2782 | |
Not Available |
Full Name | Laurel Elizabeth Busch |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 10685 101st Ave Nw, Columbus, North Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831733039 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 097564 (Iowa) | Primary |
Mailing Address | Practice Location Address |
---|---|
Laurel Elizabeth Busch, OTR/L 10685 101st Ave Nw, Columbus, ND 58727-9420 Ph: (701) 339-2782 | Laurel Elizabeth Busch, OTR/L 10685 101st Ave Nw, Columbus, ND 58727-9420 Ph: (701) 339-2782 |
News Archive
An electroencephalogram (EEG) study of adolescents with autism spectrum disorder (ASD) identified a neural signal that may help explain the variation of how those with ASD perceive or understand the mental states of others (called "Theory of Mind").
A recent study conducted by Austin Health, Australia, has revealed that the serum level of procalcitonin can be a strong indicator of bacterial co-infection with COVID-19.
Writing in the latest edition of Australian Prescriber, Associate Professor Helen Reddel, research leader at the Woolcock Institute of Medical Research says many people are prescribed higher doses than necessary. Most people do not use their inhalers correctly, leading to poor clinical outcomes and wasted medicines.
5% to 10% of all breast cancers are monogenic in origin. In other words, there is a mutation of the genes BRCA1, BRCA2 or other high-risk genes. In this edition of Deutsches Ă„rzteblatt International, Alfons Meindl of the Klinikum rechts der Isar and coauthors report on new insights into the pathogenesis and treatment of hereditary breast and ovarian cancer and newly-discovered risk genes.
Therakos, Inc., a pioneer in the development of an innovative immune modulation therapy called extracorporeal photopheresis (ECP), today launched Lighting Up Lives, a 25-year anniversary campaign and year-long global initiative that honours the lives of patients with serious immune diseases impacted by ECP, as well as the healthcare professionals, caregivers and treatment centres that support them every step of the way.
› Verified 8 days ago